Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-626-4 | CAS number: 108-89-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In vitro bacteria reverse mutation: Weight of evidence: A couple of experimental studies with the substance are available for in vitro genetic toxicity following a method similar to guideline OECD 471. The substance was tested with S. typhimurium strains TA 97, TA 98, TA 100 and TA 1535 with and without S9 mix in one study and with S. typhimurium strains TA 1538, TA 1535, TA 1537, TA 98 and TA 100 with S9 mix in the other. All results were negative. Thus, the substance can be considered as not mutagenic in all strains tested with and without metabolic activation.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Reliable with restrictions; basic data given, comparable to guidelines/standards.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
precedes development of guideline- Deviations:
- yes
- Remarks:
- Not tested in the absence of metabolic activation
- Principles of method if other than guideline:
- Plate incorporation assay
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- standard test strains
- Species / strain / cell type:
- S. typhimurium TA 1538
- Metabolic activation:
- with
- Metabolic activation system:
- Liver fraction (S9) from Aroclor-induced rats.
- Test concentrations with justification for top dose:
- 0.01, 0.05, 0.10, 0.50 and 1.0 mg/plate
- Vehicle / solvent:
- Dimethylsulfoxide was used as the solvent and negative control.
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- 2-acetylaminofluorene
- Remarks:
- for strain TA 100
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- For strain TA 98
- Details on test system and experimental conditions:
- The plate incorporation assay was employed. The bacterial cultures (approximately 2 x 108 cells/plate) were treated with the test substance in the presence of S9 mix, , in two ml of molten top agar and poured over previously prepared Vogel-Bonner minimal agar medium. Plates were incubated at 37 degrees C for 48 hours before counting the reverted colonies. General toxicity was determined over a 1000 fold concentration range, up to a maximum of 5 mg/plate. The experiments were repeated independently at least two times in the nontoxic and effect dose range using three plates per dose.
- Evaluation criteria:
- No specific data, other than critical slope values of the linear dose-response curves.
- Statistics:
- The specific mutagenic activities were determined from the slope values of linear dose-response curves and were given as revertants per mg of the test substance.
- Key result
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Although all the tester strains were used, TA98 was the most sensitive strain and was the strain for which most data were reported in this article.
- Conclusions:
- Mutagenic activity was not observed with this test substance in the presence of S9 mix.
- Executive summary:
The genetic toxicity in vitro of the test item has been tested following a method similar to guideline OECD 471. It has been tested in S. typhimurium strains: TA 1538, TA 1535, TA 1537, TA 98 and TA 100. It has been used DMSO as vehicle and for positive controls 2-acetylaminofluorene and benzo(a)pyrene.
Mutagenic activity was not observed with this test substance in the presence of S9 mix.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- not specified
- Remarks:
- no data on the test report
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- S. typhimurim strains: Strain TA100, strain TA1535, strain TA97, Strain TA98
- Species / strain / cell type:
- S. typhimurium TA 1535
- Species / strain / cell type:
- S. typhimurium TA 100
- Species / strain / cell type:
- S. typhimurium TA 98
- Species / strain / cell type:
- S. typhimurium TA 97
- Metabolic activation:
- with and without
- Metabolic activation system:
- Extracts of rat or hamster liver enzymes (S9 mix).
- Test concentrations with justification for top dose:
- Initial test concentrations: 100, 333, 1000, 3333 and 10000 µg/plate.
- Details on test system and experimental conditions:
- PRINCIPLE OF ASSAY
Each of the bacterial strains has a mutation that prevents it from making an amino acid (a protein building block) required for normal cell growth. The S. typhimurium strains are unable to manufacture histidine; the E. coli strain cannot manufacture tryptophan. The tester strains will not be able to grow without amino acid supplementation, unless the mutated gene is changed back to the correct DNA sequence (reversion mutation). Being exposed to a mutagenic chemical increases the chance that the mutant gene will be restored to the correct sequence, which allows the bacteria to grow and form colonies. Each substance under study is tested in a variety of bacterial strains with different types of altered DNA sequences in order to provide a comprehensive assessment of the mutagenic potential of the substance.
PREPARING CULTURES
Multiple sets of cultures are prepared using a range of doses and different amounts of liver enzymes for each bacterial strain. Each culture is prepared in a test tube containing a suspension of one bacterial strain and either an S9 mix or plain buffer solution. Then the test substance is added. Negative control cultures are established using the same ingredients, but without the test substance. Positive control cultures are established using known mutagens active in particular bacterial strains and metabolic conditions (for example, with or without S9). Once prepared, each culture is incubated for 20 minutes at 37° C. Agar is then added to the cultures, and the contents of each tube are poured onto the surface of a Petri dish that was prepared with standard bacterial culture medium. The plates are then incubated, usually for two days. - Evaluation criteria:
- To validate the test, a trained investigator compares the number of colonies on the chemical-treated plates to the number of colonies on the negative control plates. If the substance under test is mutagenic, the chemical-treated plates will have a much greater number of colonies than the negative control plates.
- A positive response is a reproducible, dose-related increase in mutant colonies in any single strain, with or without the addition of S9 metabolic enzymes. While there is no minimum percentage of increase required for a result to be considered positive, a twofold increase in mutant colonies in a treated plate is usually considered to be a positive (mutagenic) response.
- An equivocal response is any increase that is not reproducible, not dose-related, or not high enough in magnitude to be considered positive.
- A negative response occurs when no increases in mutant colonies are seen in the cultures treated with the test chemical, compared with the control. - Key result
- Species / strain:
- S. typhimurium TA 97
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- Mutagenic activity was not observed with this test substance in the presence or absence of S9 mix.
- Executive summary:
The genetic toxicity in vitro of the test item has been tested following a method similar to guideline OECD 471. It has been tested in S. typhimurium strains: Ta 97, TA 98, TA 100 and TA 1535. Mutagenic activity was not observed with this test substance with and without metabolic activity.
Referenceopen allclose all
Strain TA100 | ||||||
Dose (µg/Plate) | Without S9 | Without S9 | With 10% Rat S9 | With 30% Rat S9 | With 10% Hamster S9 | With 30% Hamster S9 |
Vehicle control | 109 +/- 7.5 | 142 +/- 7.2 | 119 +/- 17.6 | 110 +/- 3.5 | 95 +/- 4.3 | |
100 | 100 +/- 3.3 | 121 +/- 14.5 | 132 +/- 6.8 | 142 +/- 2.3 | 130 +/- 6.5 | 111 +/- 2.0 |
333 | 98 +/- 5.8 | 128 +/- 13.0 | 125 +/- 11.0 | 125 +/- 8.5 | 114 +/- 8.4 | 101 +/- 5.2 |
1000 | 106 +/- 1.5 | 131 +/- 2.0 | 142 +/- 0.7 | 116 +/- 3.2 | 124 +/- 11.7 | 102 +/- 4.7 |
3333 | 117 +/- 0.9 | 146 +/- 9.5 | 137 +/- 4.7 | 101 +/- 10.4 | 121 +/- 6.1 | 96 +/- 6.1 |
10000 | Toxic | 106 +/- 3.5 | 101 +/- 1.3 | 80+/- 3.4 | 90 +/- 6.4 | 83 102 +/- 4.7 8.7 |
Trial Summary | Negative | Negative | Negative | Negative | Negative | Negative |
Positive control | 818 +/- 29.6 (4) | 947 +/- 19.1 (4) | 480 +/- 34.5 (3) | 427 +/- 9.8 (5) | 617 +/- 12.9 (1) | 554 102 +/- 22.4 (3) |
Strain TA1535 | ||||||
Dose (µg/Plate) | Without S9 | Without S9 | With 10% Rat S9 | With 30% Rat S9 | With 10% Hamster S9 | With 30% Hamster S9 |
Vehicle control | 9 +/- 1.5 | 12 +/- 3.0 | 14 +/- 1.9 | 10 +/- 1.5 | 7 +/- 0.6 | 7 +/- 0.3 |
100 | 11 +/- 1.3 | 13 +/- 1.0 | 12 +/- 1.5 | 15 +/- 1.5 | 5 +/- 1.0 | 10 +/- 1.9 |
333 | 10 +/- 2.1 | 11 +/- 1.8 | 8 +/- 1.8 | 10 +/- 1.3 | 9 +/- 2.8 | 10 +/- 1.2 |
1000 | 13 +/- 2.3 | 11 +/- 3.5 | 10 +/- 1.2 | 11 +/- 1.8 | 5 +/- 1.9 | 9 +/- 1.9 |
3333 | 12 +/- 2.7 | 13 +/- 1.5 | 10 +/- 1.7 | 12 +/- 2.0 | 13 +/- 3.5 | 9 +/- 0.6 |
10000 | 3 +/- 1.8 | 8 +/- 0.7 | 6 +/- 0.6 | 10 +/- 2.0 | 4 +/- 1.8 | 5 +/- 0.9 |
Trial Summary | Negative | Negative | Negative | Negative | Negative | Negative |
Positive control | 818 +/- 29.6 (4) | 947 +/- 19.1 (4) | 58 +/- 2.0 (5) | 82 +/- 7.3 (6) | 82 +/- 7.3 (3) | 147 +/- 123 (5) |
Strain TA97 | ||||||
Dose (µg/Plate) | Without S9 | Without S9 | With 10% Rat S9 | With 30% Rat S9 | With 10% Hamster S9 | With 30% Hamster S9 |
Vehicle control | 157 +/- 5.0 | 117 +/- 3.4 | 147 +/- 4.3 | 191 +/- 7.3 | 116 +/- 9.9 | 183 +/- 2.0 |
100 | 152 +/- 5.4 | 121 +/- 4.5 | 145 +/- 5.7 | 190 +/- 2.7 | 120 +/- 7.9 | 167 +/- 2.5 |
333 | 124 +/- 11.0 | 129 +/- 2.6 | 159 +/- 9.3 | 214 +/- 3.0 | 130 +/- 16.4 | 145 +/- 14.2 |
1000 | 161 +/- 10.3 | 120 +/- 14.0 | 187 +/- 7.5 | 210 +/- 7.3 | 146 +/- 2.6 | 166 +/- 6.7 |
3333 | 162 +/- 1.5 | 130+/- 3.5 | 181 +/- 7.8 | 188 +/- 10.0 | 143 +/- 7.0 | 155 +/- 7.0 |
10000 | 70 +/- 7.0 | 104 +/- 14.3 | 138 +/- 8.0 | 140+/- 9.2 | 123 +/- 9.8 | 122 +/- 3.7 |
Trial Summary | Negative | Negative | Negative | Negative | Negative | Negative |
Positive control | 479 +/- 12.5 (8) | 479 +/- 12.5 (8) | 450 +/- 15.7 (3) | 560 +/- 3.5 (5) | 577 +/- 32.9 (7) | 605 +/- 1.5 (3) |
Strain TA98 | ||||||
Dose (µg/Plate) | Without S9 | Without S9 | With 10% Rat S9 | With 30% Rat S9 | With 10% Hamster S9 | With 30% Hamster S9 |
Vehicle control | 17 +/- 2.5 | 18 +/- 1.2 | 26 +/- 1.9 | 16 +/- 3.8 | 22 +/- 3.5 | 18 +/- 3.2 |
100 | 16 +/- 1.5 | 15 +/- 0.6 | 21 +/- 2.6 | 20 +/- 2.3 | 25 +/- 2.1 | 18 +/- 3.5 |
333 | 17 +/- 2.6 | 19 +/- 4.0 | 24 +/- 4.7 | 17 +/- 2.0 | 15 +/- 5.8 | 19 +/- 4.3 |
1000 | 16 +/- 2.9 | 21 +/- 4.6 | 21 +/- 3.3 | 12 +/- 1.2 | 27 +/- 5.5 | 19 +/- 2.5 |
3333 | 10 +/- 1.5 | 23 +/- 3.3 | 25 +/- 3.6 | 11 +/- 1.5 | 26 +/- 1.9 | 16 +/- 4.4 |
10000 | Toxic | 11 +/- 2.0 | 16 +/- 1.9 | 11 +/- 2.0 | 21 +/- 3.7 | 9 +/- 1.0 |
Trial Summary | Negative | Negative | Negative | Negative | Negative | Negative |
Positive control | 600 +/- 50.9 (9) | 472 +/- 41.4 (9) | 338 +/- 11.2 (3) | 215 +/- 11.2 (5) | 215 +/- 10.1 (7) | 242 +/- 18.7 (3) |
1: Vehicle control: water
2: 1.0 µg/plate Sodium Azide
3: 2.0 µg/plate 2-Aminoanthracene
4: 5.0 µg/plate sodium azide
5: 5.0 µg/plate 2-Aminoanthracene
6: 10.0 µg/plate 2-Aminoanthracene
7: 1.0 µg/plate 2-Aminoanthracene
8: 50.0 µg/plate 9-Aminoacridine
9:2.5 µg/plate 4-Nitro-O-Phenylenediamine
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Based on the available information, the substance is considered to be negative for genetic toxicity, and therefore the substance is not classified in accordance with CLP Regulation (EC) no 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.